• 1. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Introduction to Compound CAS No. 107492-79-5: (Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine

(Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine (CAS No. 107492-79-5) is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as Z-N-(1-pyridin-4-ylethylidene)hydroxylamine, is characterized by its unique structural features and potential biological activities. This introduction aims to provide a comprehensive overview of the compound, including its chemical structure, synthesis methods, biological properties, and recent research advancements.

The chemical structure of (Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine is composed of a pyridine ring linked to an ethylidene group, which is further connected to a hydroxylamine moiety. The presence of the hydroxylamine group imparts unique reactivity and functional properties to the molecule. The Z configuration of the double bond is crucial for its biological activity and stability.

Synthesis of (Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine typically involves a series of well-defined chemical reactions. One common method involves the condensation of 4-acetylpyridine with hydroxylamine in the presence of a suitable base. The reaction conditions, such as temperature and solvent choice, play a critical role in achieving the desired Z configuration. Recent advancements in synthetic methodologies have focused on improving yield and selectivity, making the compound more accessible for large-scale production.

The biological properties of (Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine have been extensively studied due to its potential therapeutic applications. Research has shown that this compound exhibits significant antioxidant and anti-inflammatory activities. These properties are attributed to its ability to scavenge free radicals and modulate inflammatory pathways. Additionally, studies have demonstrated that (Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine can inhibit the activity of specific enzymes involved in disease progression, making it a promising candidate for drug development.

In the context of medicinal chemistry, (Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine has been explored for its potential in treating various diseases. For instance, it has shown promise in preclinical studies for the treatment of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. The compound's ability to cross the blood-brain barrier and target key pathological mechanisms makes it an attractive therapeutic agent in these conditions.

Recent research has also highlighted the potential of (Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine in cancer therapy. Studies have demonstrated that it can induce apoptosis in cancer cells while sparing normal cells, suggesting its selective cytotoxicity. This property is particularly valuable in developing targeted cancer therapies with reduced side effects.

The safety profile of (Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine is another important aspect that has been investigated. Preclinical toxicology studies have shown that the compound exhibits low toxicity at therapeutic concentrations, making it a viable candidate for further clinical development. However, ongoing research is necessary to fully understand its long-term safety and efficacy.

In conclusion, (Z)-N-[1-(pyridin-4-yl)ethylidene]hydroxylamine (CAS No. 107492-79-5) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique chemical structure and favorable biological properties make it an attractive target for further research and development in the fields of medicinal chemistry and pharmaceutical sciences. As research continues to advance, it is likely that new insights into the mechanisms of action and therapeutic potential of this compound will emerge, paving the way for innovative treatments for various diseases.

• 61890-32-2(Methanone, 3-pyridinyl-4-pyridinyl-, oxime, (Z)-)
• 3240-24-2(Pyridinium,4-[1-(hydroxyimino)ethyl]-1-methyl-, iodide (1:1))
• 5973-83-1(1-(3-pyridyl)ethanone oxime)
• 107445-21-6(1-(4-Pyridinyl)-1-ethanone Oxime)
• 61890-35-5(Ethanone, 2-phenyl-1-(4-pyridinyl)-, oxime, (E)-)
• 61890-34-4(Ethanone, 2-phenyl-1-(4-pyridinyl)-, oxime, (Z)-)
• 216753-07-0(Ethanone,1-(4-pyridinyl)-, O-methyloxime, (1E)-)
• 1194-99-6(1-(4-pyridyl)ethanone oxime)
• 106881-77-0((E)-1-(3-pyridyl)ethanone oxime)
• 58088-20-3(Methanone, 3-pyridinyl-4-pyridinyl-, oxime)